• By ICR Secretariat
  • Posted Wednesday, February 17, 2021

CureVac’s COVID-19 vaccine begins rolling review with EMA

http://www.pharmatimes.com/news/curevacs_covid-19_vaccine_begins_rolling_review_with_ema_1363316

German biopharmaceutical company CureVac has announced the initiation of a rolling review with the European Medicines Agency (EMA) for its mRNA-based COVID-19 vaccine, CVnCoV.